Senegal Declares Victory Over Trachoma: A Major Step in Global Neglected Tropical Disease Elimination
Senegal has been officially validated by the World Health Association (WHO) as having eliminated trachoma as a public health problem – a landmark achievement marking the second neglected tropical disease (NTD) eradicated within the country. This success, built on decades of dedicated effort, underscores the power of targeted public health interventions and collaborative partnerships in tackling preventable blindness and improving the lives of vulnerable populations.
For over a century, trachoma has cast a long shadow over communities in Senegal, causing meaningful suffering and vision loss.This validation represents not just a public health milestone,but a testament to the unwavering commitment of frontline health workers,local communities,government leaders,and international partners like the WHO and the International Trachoma Initiative (ITI). As Dr. Jean-Marie vianny Yameogo, WHO Representative in Senegal, stated, “Today, we close a chapter that began over a hundred years ago, united with pride, gratitude and resolve.”
Understanding Trachoma: A Preventable Cause of Blindness
Trachoma is an infectious eye disease caused by the bacterium Chlamydia trachomatis. It spreads through close personal contact, particularly via contaminated hands, shared towels, and flies that land on infected eyes and noses. The disease thrives in environments characterized by poor hygiene, overcrowded living conditions, and limited access to clean water and sanitation. Left untreated, trachoma progresses through stages of inflammation, scarring, and ultimately, irreversible blindness.
The SAFE Strategy: A Holistic Approach to Elimination
Senegal’s success is directly attributable to the implementation of the WHO’s recommended SAFE strategy:
Surgery: Corrective surgery to address trachomatous trichiasis - a late-stage complication where inward-turning eyelashes scratch the cornea, causing pain and vision loss.
Antibiotics: Mass drug management (MDA) of azithromycin, generously donated by Pfizer through the ITI, to clear active infections within communities.
Facial Cleanliness: Public health campaigns promoting regular face washing, particularly among children, to reduce transmission.
Environmental Enhancement: Investments in improving access to clean water sources and sanitation facilities, addressing the root causes of transmission.
The Trachoma Initiative played a crucial role in supporting these efforts, carrying out extensive public awareness campaigns focused on facial cleanliness and advocating for improved water and sanitation infrastructure.
global Progress and Remaining Challenges
Senegal joins a growing list of 25 countries validated by the WHO for trachoma elimination: Benin, burundi, Cambodia, China, Gambia, Ghana, India, islamic Republic of Iran, Iraq, Lao People’s Democratic Republic, Malawi, Mali, Mauritania, Mexico, Morocco, Myanmar, Nepal, Oman, Pakistan, Papua New Guinea, saudi Arabia, Togo, Vanuatu, and Viet Nam. These nations are among the 57 countries globally that have eliminated at least one NTD.
Despite this encouraging progress, trachoma remains a significant public health problem in 32 countries, affecting an estimated 103 million people. The WHO African Region bears the brunt of the global burden, with 93 million people (90% of the worldwide total) living in areas requiring intervention as of April 2024.
Currently, 20 countries in the African Region require ongoing trachoma elimination programs: Algeria, Angola, Burkina Faso, Cameroon, Central Africa Republic, Chad, Côte d’Ivoire, Democratic Republic of the congo, Eritrea, Ethiopia, Guinea, Kenya, Mozambique, Niger, Nigeria, South sudan, United Republic of Tanzania, Uganda, Zambia, and Zimbabwe. botswana, Guinea-Bissau, and namibia report having met the prevalence targets for elimination, though continued monitoring is essential.
Looking Ahead: The 2021-2030 NTD Roadmap
The WHO’s Roadmap for neglected Tropical diseases 2021-2030 sets ambitious targets for the prevention, control, elimination, and eradication of 20 diseases and disease groups by 2030. Continued investment in research, surveillance, and integrated NTD programs is crucial to achieving these goals.
Eliminating trachoma and other NTDs is not only a moral imperative but also a sound economic investment.Reducing the burden of these diseases alleviates suffering, improves productivity, and contributes to sustainable progress in the world’s most disadvantaged communities. Senegal’s success serves as an inspiring example of what can be achieved through sustained commitment, strategic partnerships, and a focus on evidence-based interventions.
Resources:
* World Health organization (WHO) – Trachoma: [https://www.who.int/news-room/fact-sheets/detail/trachoma
Keep reading